UBS lowers Syndax Pharmaceuticals price target on revenue outlook
What it means
- What to watch: $SNDX had its price target revised — one analyst's number is a data point, not a thesis.
- How the stock is trading: $SNDX -3.53% in the latest session.
- Timing: It came out pre-market, so the next session was the first that could react.
Where the stock stands
$SNDX last changed hands at $13.65, -3.53% on the session, 47% below its 52-week high of $25.59 and 6.7% above its low of $12.80 — within a tenth of its 52-week low. Over the year it has ranged 100% from low to high: a very wide band; big swings are routine for this one, not news. These are latest-session quotes, not live prices — the live tape is on the $SNDX page.
How much coverage it is getting
In the last 30 days Wook has filed 3 stories about $SNDX — 1 of them this week. At its 30-day pace you would expect about 1 a week, so this week is somewhat busier than usual. Across those stories 0 read bullish, 2 neutral and 1 bearish. This one reads neutral, so it sits in step with most of the run. 2 of the 3 (67%) came from Investing.com itself, so the count says as much about how often Investing.com hits publish as about how much attention there is — the other outlets are the better gauge. 12 related stories — same name or same desk — are lined up beside this one if you want the whole thread.
The bigger picture
With earnings, the number matters less than the number versus expectations — and guidance often matters more than both. A beat paired with a soft outlook can still get a cold reception. Wook's supply-chain scanner has Health Care reading calm today: no unusual stress in the filings and disclosures it watches.
Coming up
$SNDX earnings in 2 days. These were on the calendar before this story and are not caused by it, but the nearest is close enough that the next hard numbers on this company are almost here.
What to watch next
For the receipts, the $SNDX page has the full chart, the filings and the valuation model these figures come from. Because one outlet dominates the coverage, reading another outlet on the same story is the quickest check on whether it is being confirmed or just repeated. Wook AI, above, can pull live figures and run the numbers on request — how far $SNDX is from its high, or how this week's coverage compares.
How this analysis was made
Investing.com published it, and Wook filed it under Earnings. No strongly worded term either way, so it reads neutral at low severity — a factual headline rather than a charged one. It was matched to $SNDX. The publisher gave no preview text, and nothing has been written in to fill the gap.
The tone and severity labels come from a fixed word list — no editor, no AI, no crystal ball — so they describe how a story is worded, not what happens next. They are not a forecast or a recommendation, and a same-day move does not mean this story caused it. Not investment advice.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Investing.com published this on August 21, 2026. $SNDX has moved -30.53% ($19.65 to $13.65). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.